CIK 0001541157 · Non-accelerated filer<br>Smaller reporting company
Akari Therapeutics Plc
Sign in to watch- Ticker
- AKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- EIN
- 981034922
- Phone
- (929) 274-7510
- Business address
- 401 EAST JACKSON STREET, SUITE 3300, TAMPA, FL, 33602
- Former names
- Celsus Therapeutics Plc., Morria Biopharmaceuticals PLC
- DEFA14A Proxy Proxy Materials
- 8-K Event Other events
- SC 13G Stake Amended Statement of Ownership
- DEFA14A Proxy Proxy Materials
- 8-K Event Material agreement · Unregistered share sale · Shareholder rights changed
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
- 10-Q Report Quarterly Report
- DEFM14A Deal DEFM14A
- 8-K Event Executive or director change · Shareholder vote results
- 8-K Event Regulation FD disclosure · Other events
- DEFA14A Proxy Proxy Materials
- PREM14A Deal PREM14A
- 8-K Event Material agreement · Unregistered share sale · Change in control · Executive or director change
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
Page 31 of 38 · 746 filings